Clinical & Scientific

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

From nano-surfactants to pharmaceuticals, SureNano Science is betting its future on a novel obesity drug. Can this microcap survive the big leagues?

With its new CCO, the AI health-tech firm aims to commercialize its patient-data platform, tackling billion-dollar delays in drug development.

A new global partnership aims to solve key bottlenecks in regenerative medicine by providing standardized, high-quality umbilical cord stem cells to researchers.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

A devastating infant liver disorder meets a potential breakthrough. Satellite Bio's novel cell therapy just received a critical FDA nod, paving the way for trials.

Strata Critical Medical acquires Ohio Valley Perfusion Associates, a strategic move to consolidate the fragmented perfusion market and boost lifesaving care.

Digital health giant Hinge Health is expanding beyond muscle pain, launching a new program that combines a wearable device with AI to tackle migraine.

A new AI platform, SAVA, launched by EverythingALS, promises to connect ALS patients with clinical trials, tackling a major barrier in the search for a cure.

As AI accelerates drug approvals, a new bottleneck emerges. Firms like Totaligent are betting on the infrastructure needed to get therapies to patients.

After 16 years of growth and modernization, Executive Director Darren Gilmour steps down, leaving Canada's national academy at a pivotal crossroads.

Formerly LA Cancer Network, Oncura Health's new Los Alamitos clinic brings advanced, physician-led oncology services to a competitive Orange County market.

A new study reveals that poor muscle quality, measured by advanced MRI, is a powerful predictor of death in CKD patients, shifting focus to systemic health.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

With its Nasdaq debut, Lakewood-Amedex aims to accelerate its novel antimicrobial, Nu-3, a new weapon against antibiotic-resistant diabetic foot ulcers.

ENA Respiratory appoints GSK veteran Melissa Faris to its board, a strategic move signaling an accelerated push for its innovative virus-agnostic nasal spray.